Gilteritinib Fumarate CAS 1254053-84-3

Purity 97%+In StockPharmaceutical Standards
CAS No.1254053-84-3
Molecular Formula2*C29H44N8O3
Molecular WeightN/A
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

Gilteritinib Fumarate CAS 1254053-84-3 chemical structure

Description

CATO supplies Gilteritinib Fumarate (CAS 1254053-84-3), a certified reference material (molecular formula C29H44N8O3C4H4O4, MW 668.80 g/mol) for analytical method development and quality control.

Based on its molecular formula C29H44N8O3C4H4O4, Gilteritinib Fumarate contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 668.80 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.

As a certified reference material (CRM), Gilteritinib Fumarate meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular Formula2*C29H44N8O3 C4H4O4
Molecular Weight668.80 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)14.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1990
Nitrogen Atoms8

Related Gilteritinib Standards

Recommended Standards

Why CATO?